These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7294751)

  • 21. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumatic dry granulation: potential to improve roller compaction technology in drug manufacture.
    Sandler N; Lammens RF
    Expert Opin Drug Deliv; 2011 Feb; 8(2):225-36. PubMed ID: 21222551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bioavailability of drug forms of tetracycline-group semisynthetic preparations for internal use].
    Zak AF; Batuashvili TA
    Antibiotiki; 1983 Sep; 28(9):659-63. PubMed ID: 6638980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
    McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
    Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Manufacture of tetracaine hydrochloride tablets using direct compression and moist granulation].
    Gazikalović E; Obrenović D; Nidzović Z; Colić O
    Vojnosanit Pregl; 2002; 59(6):621-4. PubMed ID: 12557620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of Stokes deformation number as a predictive tool for material exchange behaviour of granules in the 'equilibrium phase' in high shear granulation.
    Bouwman AM; Visser MR; Meesters GM; Frijlink HW
    Int J Pharm; 2006 Aug; 318(1-2):78-85. PubMed ID: 16713144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug liberation from floating capsules in the rotating-flask solubility tester].
    Koch HP; Mertz M; Zinterhof G
    Pharmazie; 1987 May; 42(5):312-5. PubMed ID: 3671440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of sodium dicloxacillin with different dosage levels].
    Mazzei CM; Andrés Bellomo J; Gherardi CR; Galán HM
    Rev Clin Esp; 1970 Mar; 116(5):443-52. PubMed ID: 5528061
    [No Abstract]   [Full Text] [Related]  

  • 35. "Performance qualification of a new hypromellose capsule. Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules and Part II. Disintegration and dissolution comparison between two types of hypromellose capsules" by M. Sherry Ku et al.
    Jones BE; Podczeck F
    Int J Pharm; 2012 Feb; 423(2):589-92. PubMed ID: 22155286
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of sensor elements to control drug release from capsular drug delivery systems.
    Gröning R; Danco I; Müller RS
    Int J Pharm; 2007 Aug; 340(1-2):61-4. PubMed ID: 17462841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of different beta-lactams antibiotics in pharmaceutical preparations using micellar electrokinetic capillary chromatography.
    Pérez MI; Rodríguez LC; Cruces-Blanco C
    J Pharm Biomed Anal; 2007 Jan; 43(2):746-52. PubMed ID: 16978821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H; Wirbitzki E
    Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
    Tao T; Zhao Y; Wu J; Zhou B
    Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.